[ad_1] The National Institute of Hygiene "Rafael Rangel" (INHRR), entity attached to the Ministry of Health, issued a Special Pharmaceutical Alert No. 013/2018 in which it states that it ordered the recall …
Read More »
[ad_1] The National Institute of Hygiene "Rafael Rangel" (INHRR), an entity attached to the Ministry of Health, announced that They were taking preventative measures to remove from the market all products containing …
Read More »
[ad_1] July 25, 2018 10:34 | Updated on July 25, 2018 11:10 The National Institute of Hygiene Rafael Rangel (Inhrr) issued a statement to inform about certain drugs with the active ingredient …
Read More »
[ad_1] The National Association of Drugs, Food and Medical Technology (ANMAT) ordered yesterday the preventive recall of the market from a series of specific batches of a known antihypertensive drug, valsartan, for …
Read More »
[ad_1] The Bolivian health authorities yesterday issued a health alert to suspend the marketing of drugs containing the active substance known as Valsartan. "We have the obligation as a state to protect …
Read More »
[ad_1] This medicine is used to treat hypertension and reduce the risk of heart attack or stroke Source: File National Administration of Drugs, Food and Drug medical technologies (Anmat) said it ordered …
Read More »
[ad_1] The Ministry of Health yesterday ordered the removal of drugs containing the substance called valsartan, which comes from the Zhejiang Huahai Pharmaceuticais Laboratory, China. However, the departmental health department (head office) …
Read More »
[ad_1] The Ministry of Health has decided to suspend the sale of drugs containing valsartan of Chinese origin suspected of containing a carcinogenic element. The decision was announced by the National Agency …
Read More »
[ad_1] Ministry of Health warns active ingredient Valsartan contains potentially toxic impurities Digempas was the subject of further investigation and was able to verify that none of the products declared by EMA …
Read More »
[ad_1] July 18, 2018. – The laboratory VIVAX has informed by a declaration, the voluntary withdrawal of products containing the active ingredient valsartan, such as Presincal, Valsartan and Varteral, due to the …
Read More »